From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma.

chromaffin system machine learning pheochromocytoma predictive score recurrence prediction

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
03 Jun 2022
Historique:
received: 09 04 2022
revised: 03 05 2022
accepted: 30 05 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

A reliable prediction of the recurrence risk of pheochromocytoma after radical surgery would be a key element for the tailoring/personalization of post-surgical follow-up. Recently, our group developed a multivariable continuous model that quantifies this risk based on genetic, histopathological, and clinical data. The aim of the present study was to simplify this tool to a discrete score for easier clinical use. Data from our previous study were retrieved, which encompassed 177 radically operated pheochromocytoma patients; supervised regression and machine-learning techniques were used for score development. After Cox regression, the variables independently associated with recurrence were tumor size, positive genetic testing, age, and PASS. In order to derive a simpler scoring system, continuous variables were dichotomized, using > 50 mm for tumor size, ≤ 35 years for age, and ≥ 3 for PASS as cut-points. A novel prognostic score was created on an 8-point scale by assigning 1 point for tumor size > 50 mm, 3 points for positive genetic testing, 1 point for age ≤ 35 years, and 3 points for PASS ≥ 3; its predictive performance, as assessed using Somers’ D, was equal to 0.577 and was significantly higher than the performance of any of the four dichotomized predictors alone. In conclusion, this simple scoring system may be of value as an easy-to-use tool to stratify recurrence risk and tailor post-surgical follow-up in radically operated pheochromocytoma patients.

Identifiants

pubmed: 35740332
pii: biomedicines10061310
doi: 10.3390/biomedicines10061310
pmc: PMC9219670
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

BMJ. 2006 May 6;332(7549):1080
pubmed: 16675816
Virchows Arch. 2019 Jun;474(6):721-734
pubmed: 30868297
J Intern Med. 2016 Dec;280(6):559-573
pubmed: 27165774
Eur J Endocrinol. 2016 Oct;175(4):R135-45
pubmed: 27080352
Hypertens Res. 2020 Jun;43(6):500-510
pubmed: 31586159
Horm Metab Res. 2012 May;44(5):385-9
pubmed: 22351478
Eur J Endocrinol. 2002 Jul;147(1):85-94
pubmed: 12088924
Surgery. 2014 Dec;156(6):1523-7; discussion 1527-8
pubmed: 25456947
Endocr Relat Cancer. 2014 May 06;21(3):405-14
pubmed: 24521857
Clin Endocrinol (Oxf). 2017 Nov;87(5):440-450
pubmed: 28746746
Eur J Endocrinol. 2022 Feb 15;186(3):399-406
pubmed: 35363157
J Clin Endocrinol Metab. 2005 Apr;90(4):2110-6
pubmed: 15644401
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374
pubmed: 30715419
Eur J Cancer. 2012 Jul;48(11):1739-49
pubmed: 22036874
Eur J Clin Invest. 2011 Oct;41(10):1121-8
pubmed: 21692797
Surgery. 2018 Sep;164(3):511-517
pubmed: 29929757
PLoS One. 2017 Nov 8;12(11):e0187398
pubmed: 29117221
J Clin Endocrinol Metab. 2011 Mar;96(3):717-25
pubmed: 21190975
J Intern Med. 2009 Jul;266(1):19-42
pubmed: 19522823
Endocr Connect. 2016 Nov;5(6):89-97
pubmed: 27852633
Hypertens Res. 2020 Nov;43(11):1141-1151
pubmed: 32778780
Am J Surg Pathol. 2002 May;26(5):551-66
pubmed: 11979086
Eur J Endocrinol. 2016 May;174(5):G1-G10
pubmed: 27048283
Korean J Urol. 2011 Apr;52(4):241-6
pubmed: 21556209
J Intern Med. 2005 Jul;258(1):55-66
pubmed: 15953133
Curr Opin Endocrinol Diabetes Obes. 2019 Jun;26(3):146-154
pubmed: 30893083
J Urol. 2011 May;185(5):1583-90
pubmed: 21419457
PLoS One. 2016 Dec 16;11(12):e0168413
pubmed: 27992508
Nat Rev Endocrinol. 2015 Feb;11(2):101-11
pubmed: 25385035
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Psychol Methods. 2002 Mar;7(1):19-40
pubmed: 11928888

Auteurs

Mirko Parasiliti-Caprino (M)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Fabio Bioletto (F)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Chiara Lopez (C)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Martina Bollati (M)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Francesca Maletta (F)

Department of Oncology, University of Turin, 10043 Orbassano, Italy.
Pathology Unit, City of Health and Science University Hospital of Turin, 10126 Turin, Italy.

Marina Caputo (M)

Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.

Valentina Gasco (V)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Antonio La Grotta (A)

Endocrinology and Hypertension, Cardinal Massaia Hospital, 14100 Asti, Italy.

Paolo Limone (P)

Endocrinology, Diabetes and Metabolism, A.O. Ordine Mauriziano, 10128 Turin, Italy.

Giorgio Borretta (G)

Endocrinology and Metabolism, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.

Marco Volante (M)

Department of Oncology, University of Turin, 10043 Orbassano, Italy.
Pathology Unit, San Luigi Gonzaga University Hospital, 10043 Orbassano, Italy.

Mauro Papotti (M)

Department of Oncology, University of Turin, 10043 Orbassano, Italy.
Pathology Unit, City of Health and Science University Hospital of Turin, 10126 Turin, Italy.

Anna Pia (A)

Internal Medicine, Department of Biological and Clinical Sciences, University of Turin, 10043 Orbassano, Italy.

Massimo Terzolo (M)

Internal Medicine, Department of Biological and Clinical Sciences, University of Turin, 10043 Orbassano, Italy.

Mario Morino (M)

Surgery, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.

Barbara Pasini (B)

Medical Genetics, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Franco Veglio (F)

Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Ezio Ghigo (E)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Emanuela Arvat (E)

Oncological Endocrinology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Mauro Maccario (M)

Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Classifications MeSH